Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on April 14, 2021. The filing primarily serves to disclose preliminary financial results for the three-month period ended March 31, 2021, and to announce the commencement of a public offering of senior notes.
Key Financial Metrics and Capital Events
- Financial Results: The Company issued a press release (Exhibit 99.1) announcing preliminary financial results for the first quarter of 2021. The specific numerical values for revenue, profit, cash flow, margins, or debt are not contained within the text of this 8-K filing; they are referenced only as being included in the attached exhibit.
- Debt Offering: The Company announced a public offering of $25,000,000 aggregate principal amount of senior notes due 2026.
- Over-Allotment Option: Underwriters were granted a 30-day option to purchase up to an additional $3,750,000 aggregate principal amount of senior notes.
Material Changes and Outlook
The filing does not provide specific comparative data or percentage changes versus prior periods within the main text. Management commentary regarding the anticipated results for the first quarter of 2021 and the intended use of proceeds from the offering is contained in the forward-looking statements section and the attached exhibits. The Company explicitly states it does not assume an obligation to update the information furnished in this report.
Investor Verification Checklist
- Review Exhibit 99.1 for the specific preliminary revenue, net loss, and cash flow figures for the quarter ended March 31, 2021, as these are not listed in the 8-K body.
- Examine Exhibit 99.2 for the definitive terms, interest rate, and covenants of the $25 million senior notes offering.
- Verify the final closing amount of the offering, including whether the underwriters exercised the $3.75 million over-allotment option.
- Consult the Company's most recent Form 10-K for the year ended December 31, 2020, to review the full list of risk factors referenced in the forward-looking statements.